Hmbstm2.1Rjde
Targeted Allele Detail
|
Symbol: |
Hmbstm2.1Rjde |
Name: |
hydroxymethylbilane synthase; targeted mutation 2.1, Robert J Desnick |
MGI ID: |
MGI:6393999 |
Synonyms: |
R173Q |
Gene: |
Hmbs Location: Chr9:44247645-44255525 bp, - strand Genetic Position: Chr9, 24.84 cM
|
Alliance: |
Hmbstm2.1Rjde page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:275245
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
129/Sv x C57BL/6
|
|
Allele Type: |
|
Targeted (Humanized sequence) |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: A GC to AG change at position 518-519 resulting in an arginine to glutamine substitution at amino acid 173 (R173Q) was introduced in exon 10 and a loxP-flanked neomycin cassette was inserted in intron 9. The neomycin selection cassette was removed via cre-mediated recombination. This is a mutation found in human dominant acute intermittent porphyria.
(J:275245)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Hmbs Mutation: |
25 strains or lines available
|
|
Original: |
J:275245 Yasuda M, et al., Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria. Hum Mol Genet. 2019 Jun 1;28(11):1755-1767 |
All: |
1 reference(s) |
|